<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="diagnostics-10-00409-t001" orientation="portrait" position="float">
 <object-id pub-id-type="pii">diagnostics-10-00409-t001_Table 1</object-id>
 <label>Table 1</label>
 <caption>
  <p>This table highlights prominent collaborations of pharmaceutical companies and details on what these companies are working on about COVID-19 diagnostics, prevention, and treatment.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Company</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Field of COVID-19 Work</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Description of Work</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Abbott </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diagnostics</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Working on molecular (m2000 and ID NOW) and antibody tests [
     <xref rid="B126-diagnostics-10-00409" ref-type="bibr">126</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Abbvie</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treatment</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adopting its antiretroviral therapy of HIV (Lopinavir/Ritonavir) for COVID-19 [
     <xref rid="B127-diagnostics-10-00409" ref-type="bibr">127</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Amgen and Adaptive Biotechnologies</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diagnostics and Treatment</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Researching neutralizing antibodies to prevent and treat COVID-19 [
     <xref rid="B128-diagnostics-10-00409" ref-type="bibr">128</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AstraZeneca</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diagnostics, Prevention, and Treatment</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Collaborating with different university labs to manufacture COVID-19 diagnostics, treatment, and vaccines [
     <xref rid="B129-diagnostics-10-00409" ref-type="bibr">129</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BioNTech and Pfizer</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prevention</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Collaborating on a COVID-19 vaccine [
     <xref rid="B130-diagnostics-10-00409" ref-type="bibr">130</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bristol Myers Squibb</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treatment</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Collaborating with the community to accelerate therapies via potential molecule screening and testing current medications [
     <xref rid="B131-diagnostics-10-00409" ref-type="bibr">131</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eli Lilly</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treatment</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adopting its rheumatoid arthritis therapy (Baricitinib) and other antibody therapies for COVID-19 [
     <xref rid="B132-diagnostics-10-00409" ref-type="bibr">132</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Evotec</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diagnostics and Treatment</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Collaborating with the community to accelerate therapies via potential antibody screening [
     <xref rid="B133-diagnostics-10-00409" ref-type="bibr">133</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gilead</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treatment</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adopting its antiviral therapy (Remdesivir) for COVID-19 [
     <xref rid="B134-diagnostics-10-00409" ref-type="bibr">134</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GlaxoSmithKline and Sanofi (GSK)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prevention</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Collaborating on a COVID-19 vaccine using GSK’s pandemic adjuvant technology and Sanofi’s S-protein COVID-19 antigen [
     <xref rid="B135-diagnostics-10-00409" ref-type="bibr">135</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Johnson &amp; Johnson and Janssen</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prevention</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Collaborating on a COVID-19 vaccine using Janssen’s AdVac
     <sup>®</sup> and PER.C6
     <sup>®</sup> technology [
     <xref rid="B136-diagnostics-10-00409" ref-type="bibr">136</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KSQ Therapeutics</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treatment</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Using its CRISPRomics
     <sup>®</sup> to discover targets for the current COVID-19 treatments [
     <xref rid="B137-diagnostics-10-00409" ref-type="bibr">137</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Merck</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prevention and Treatment</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Researching the molecular mechanism of COVID-19 to identify potential vaccine and medicine targets for COVID-19 [
     <xref rid="B138-diagnostics-10-00409" ref-type="bibr">138</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moderna</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prevention</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Collaborating on a COVID-19 vaccine using mRNA technology [
     <xref rid="B139-diagnostics-10-00409" ref-type="bibr">139</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Novartis</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prevention</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adopting its autoimmune disease therapy (Canakinumab) for COVID-19 [
     <xref rid="B140-diagnostics-10-00409" ref-type="bibr">140</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Roche</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diagnostics and Treatment</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Researching COVID-19 antibody tests [
     <xref rid="B141-diagnostics-10-00409" ref-type="bibr">141</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Takeda, CSL Behring, Biotest, BPL, LFB, and Octapharma</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treatment</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adopting hyperimmune globulin for COVID-19 treatment [
     <xref rid="B142-diagnostics-10-00409" ref-type="bibr">142</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vir Biotechnology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diagnostics and Treatment</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Researching neutralizing antibodies to prevent and treat COVID-19 [
     <xref rid="B143-diagnostics-10-00409" ref-type="bibr">143</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
